London, UK, 16th March 2015 / Sciad Newswire / Evaluation of Pimobendan In dogs with Cardiomegaly caused by preclinical mitral valve disease (EPIC) global study led by Royal Veterinary College Professor Adrian Boswood concludes. Clear evidence of benefit of Pimobedan in global clinical trial. On 1st March 2015 the EPIC study was terminated. EPIC, standing for “Evaluation of Pimobendan In dogs…

Nutrition Integrates – The Power to Change the Market: A Danone Perspective.

Join your peers on February 26th for a complementary breakfast discussion led by graduate employment expert Charles Pickford in association with Cogent Placements to learn more about how the Industry Degree Scheme works.

Biotech and Money Congress joined by BioMedical Catalyst, delegates to meet the awards body at Congress

Selcia Scientists Elucidate Stereochemistry of Novel Antibacterial Macrocycle Teixobactin, Published in Nature and covered in The Times

Brian Lord OBE, Managing Director of PGI Cyber, Will Be a Guest Speaker at Digital Tuesday, January 6th, 2015

ZoBio and Domainex Join Forces to Deliver Crucial Drug Target Information to support FORMA Therapeutics’ Drug Discovery Programs

Cambridge, UK and Leiden, The Netherlands, 8th December 2014 / Sciad Newswire / Today ZoBio (Leiden, The Netherlands) and Domainex Ltd. (Cambridge, UK) announce a collaboration with FORMA Therapeutics (Watertown, MA, USA) to provide NMR-based structural biology services for a substantial panel of FORMA drug targets. The goal of the collaboration is to use ZoBio’s expertise in protein nuclear magnetic resonance (NMR) to elucidate the…

Taking place at the Park Plaza Riverbank on 18–19 November, the third Pharma Integrates conference brought together more than 200 senior leaders and participants to discuss the state of the industry and the key issues being faced.